- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0120597

About Aarotax Pharmaceuticals Private Limited
Data last updated:
Aarotax Pharmaceuticals Private Limited is a private limited company based in Sanand, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC104772. Its GSTIN is 24AARCA4669D1ZI (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Preeti Srivastav and Ajit Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sarkhej Bavala Road Changodar Road Nr. Navapura Stand Navapura, Sanand, Gujarat, India – 382210.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.8 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹4.49 Lakh (net margin 1.2%) and EBITDA of ₹15.17 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
As per MCA filings, the company has open charges of ₹1.15 Cr and satisfied charges of ₹90 Lakh on record.
Aarotax Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0120597). For more details, the company can be reached via its website aarotax.com.
Company details
Recognitions & Rankings of Aarotax Pharmaceuticals
Contact details
Aarotax Pharmaceuticals Private Limited's registered office is in Sanand, Gujarat. Its website is aarotax.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSarkhej Bavala Road Changodar Road Nr. Navapura Stand Navapura, Sanand, Gujarat, India – 382210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aarotax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aarotax Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aarotax Pharmaceuticals Private Limited, buy the company report.
Financials of Aarotax Pharmaceuticals Private Limited
FY 2025 filings availableAarotax Pharmaceuticals Private Limited reported revenue of ₹3.8 Cr (up 9% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 9% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aarotax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aarotax Pharmaceuticals Private Limited
Aarotax Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Srivastav | Director | 29 Jun 2024 | 2 Years 4 Months | Current |
| Ajit Kumar Srivastava Also directs: Tisenta Medicare India LLP | Director | 16 Oct 2018 | 8 Years 1 Months | Current |
Peer comparison
Aarotax Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocell Pharmaceuticals Private Limited | ₹3.81 Cr (FY 2025) | 2.0% | Manimajra, Chandigarh, India | |||
| Ziffex Pharmaceuticals Private Limited | ₹3.8 Cr (FY 2024) | 48.0% | Sonipat, Haryana, India | |||
| Aarotax Pharmaceuticals Private Limitedthis company | ₹3.8 Cr (FY 2023) | ₹4.49 Lakh | 1.2% | 9.0% | Sanand, Gujarat, India | |
| Nutraferon Private Limited | ₹3.79 Cr (FY 2025) | 104.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Aarotax Pharmaceuticals Private Limited, buy the company report.
Auditor
Aarotax Pharmaceuticals Private Limited is audited by A. C. MEHTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A. C. MEHTA & ASSOCIATES | FY 2021 | 134308W |
Shareholding
The shareholding of Aarotax Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aarotax Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2025 | 101171853 | Others | ₹1 Cr | Open | |
| 29 Oct 2024 | 100998690 | Hdfc Bank Limited | ₹14.9 Lakh | Open | |
| 10 Jun 2020 | 100346637 | Idbi Bank Limited | ₹75 Lakh | Satisfied | |
| 23 Oct 2019 | 100300517 | Others | ₹15 Lakh | Satisfied |
To see the full charge records of Aarotax Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Aarotax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aarotax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aarotax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARCA4669D1ZI | Gujarat | Active | 05 Nov 2018 |
To see the full GST registrations and return filing status of Aarotax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aarotax Pharmaceuticals Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Rupali Srivastava ceased to be Managing Director on 16 Jul 2024.
4 earlier events are in the company report.
Frequently asked questions
Aarotax Pharmaceuticals is an active private limited company based in Sanand, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC104772.
Aarotax Pharmaceuticals has 2 current directors:
- Preeti Srivastav - Director
- Ajit Kumar Srivastava - Director
The latest financial statements of Aarotax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Aarotax Pharmaceuticals is 24AARCA4669D1ZI, registered in Gujarat.
The CIN (Corporate Identification Number) of Aarotax Pharmaceuticals is U74999GJ2018PTC104772. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aarotax Pharmaceuticals was incorporated on 16 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aarotax Pharmaceuticals by revenue are Biocell Pharmaceuticals Private Limited, Ziffex Pharmaceuticals Private Limited, Nutraferon Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rupali Srivastava ceased to be Managing Director on 16 Jul 2024. Shubham Sahai Srivastava ceased to be Director on 30 Jun 2024. Preeti Srivastav was appointed as Director on 29 Jun 2024. Aarotax Pharmaceuticals has 6 board changes on record in total.
Yes, Aarotax Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0120597).
Aarotax Pharmaceuticals can be reached through the website aarotax.com. Its registered office is in Sanand, Gujarat, India.
The registered office of Aarotax Pharmaceuticals is at Sarkhej Bavala Road Changodar Road Nr. Navapura Stand Navapura, Sanand, Gujarat, India – 382210.

